Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, Pulmonary oedema
Clinical narrative: Heart attack; This spontaneous case was reported by a patient and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided.  The patient's past medical history included Bypass surgery. Concomitant products included VITAMINS NOS for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria hospitalization and medically significant). The patient was treated with Surgery (Quadruple bypass) for Myocardial infarction. At the time of the report, MYOCARDIAL INFARCTION (Heart attack) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications includes blood pressure medication, diabetes medication and medicine to stop rapid heart beat.  Patient had open heart surgery and quadruple bypass as a treatment.  Patient was unsure if it was vaccine related.  Company comment: This is a spontaneous case concerns a 68-year-old male patient, without any reported medical history who experienced the unexpected, serious (medically significant, hospitalization) adverse event of special interest Myocardial infarction. The event occurred 8 days after receiving the first dose of mRNA1273. The patient suffered from heart attack post vaccination and was treated via open heart surgery and quadruple bypass. Further details regarding the clinical course, diagnostic test done and complete treatment protocols on the patient were not provided. It was also reported that the patient was taking medications for blood pressure, diabetes and treatments to stop rapid heart beat, these concurrent conditions along with the elderly age of the patient may be considered as risk factors for myocardial infarction. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-608597 (Patient Link).; Sender's Comments: This is a spontaneous case concerns a 68-year-old male patient, without any reported medical history who experienced the unexpected, serious (medically significant, hospitalization) adverse event of special interest Myocardial infarction. The event occurred 8 days after receiving the first dose of mRNA1273. The patient suffered from heart attack post vaccination and was treated via open heart surgery and quadruple bypass. Further details regarding the clinical course, diagnostic test done and complete treatment protocols on the patient were not provided. It was also reported that the patient was taking medications for blood pressure, diabetes and treatments to stop rapid heart beat, these concurrent conditions along with the elderly age of the patient may be considered as risk factors for myocardial infarction. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.